PMID- 30078282 OWN - NLM STAT- MEDLINE DCOM- 20181211 LR - 20181211 IS - 0376-2491 (Print) IS - 0376-2491 (Linking) VI - 98 IP - 28 DP - 2018 Jul 24 TI - [Therapeutic effect of human umbilical cord mesenchymal stem cells on airway remodeling in an asthma model of rat and its possible mechanism]. PG - 2258-2263 LID - 10.3760/cma.j.issn.0376-2491.2018.28.010 [doi] AB - Objective: To observe the effect of human umbilical cord mesenchymal stem cells (hUC-MSCs) on airway remodeling in asthma model of rat and its possible mechanism. Methods: hUC-MSCs were isolated and cultured, and surface markers of hUC-MSCs were identified by flow cytometry. Forty Wistar male rats were divided into 4 groups: Control, Model, MSCs, Budesonide. The rats of Control group were sensitized and challenged by normal saline. The rats of Model, MSCs and Budesonide group were sensitized and challenged by ovalbumin (OVA) for 8 weeks. The MSCs group rats were given a tail vein injection of MSCs 0.2 ml (1x10(6) /ml) on days 35, 45, and 55 half an hour befor each OVA exposure. The Budesonide group rats were given aerosol inhalation of budesonide 2 mg two hours before each OVA exposure. Specimens were collected within 24 hours after the last OVA challenge. The parameters of airway morphological changes and the degree of airway remodeling were analyzed using Image-pro plus computer graphics. The levels of transformation growth factor (TGF) -beta(1) in bronchoalveolar lavage fluid (BALF) and serum were detected by enzyme linked immunosorbent assay (ELISA). The expressions of E-cadherin, alpha-smooth muscle actin (alpha-SMA) and fibronectin (Fn) were measured by immunohistochemistry. Results: The thickness of airway wall and smooth muscle of Model, MSCs and Budesonide group rats were significantly thicker than Control group. The levels of TGF-beta(1) in both BALF and serum of Model, MSCs and Budesonide group rats were significantly higher than Control group. The expression of E-cadherin of Model, MSCs and Budesonide group rats was significantly lower than Control group, while the expression of alpha-SMA and Fn were significantly higher. The thickness of airway wall and smooth muscle of MSCs and Budesonide group rats were significantly lower than Model group[(38.40+/-2.50, 45.34+/-0.33) vs (80.18+/-1.75) mum and (15.71+/-0.89, 18.57+/-0.67) vs (40.97+/-0.90) mum]. The levels of TGF-beta(1) in both BALF and serum of MSCs and Budesonide group were significantly lower than Model group[(3.53+/-0.43, 3.11+/-0.05) vs (20.88+/-0.37) mug/L and (31.07+/-0.89, 31.12+/-0.50) vs (70.58+/-0.39)mug/L](all P<0.01). The expressions of alpha-SMA, Fn of MSCs and Budesonide group rats were significantly lower than Model group[(0.438+/-0.057, 0.445+/-0.027) vs (0.521+/-0.030) and (0.459+/-0.041, 0.458+/-0.029) vs (0.527+/-0.022)], While the expression of E-cadherin was significantly higher[(0.308+/-0.023, 0.296+/-0.010) vs (0.256+/-0.087)](all P<0.01). Conclusion: MSCs could alleviate asthmatic airway remodeling, the mechanism of which may be associated with the inhibition of TGF-beta(1) induced epithelial-mesenchymal transition. FAU - Chang, Q AU - Chang Q AD - Department of Respiratory and Critical Care Medicine, the Second Hospital of Shanxi Medical School, Taiyuan 030001, China. FAU - Tian, X L AU - Tian XL FAU - Huo, R J AU - Huo RJ FAU - Liu, D AU - Liu D FAU - Chen, J Y AU - Chen JY FAU - Wang, X AU - Wang X FAU - Tian, X R AU - Tian XR LA - chi GR - 2016[366]/Foundation for Returnees of Human Resources and Social Security of China/ GR - 2017-8/Foundation for Returnees of Shanxi Province of China/ PT - Journal Article PL - China TA - Zhonghua Yi Xue Za Zhi JT - Zhonghua yi xue za zhi JID - 7511141 SB - IM MH - Airway Remodeling MH - Animals MH - Asthma MH - Disease Models, Animal MH - Humans MH - Male MH - *Mesenchymal Stem Cells MH - Rats MH - Rats, Wistar MH - Umbilical Cord OTO - NOTNLM OT - Airway remodeling OT - Asthma OT - Epithelial-mesenchymal transition OT - Mesenchymal stem cells EDAT- 2018/08/07 06:00 MHDA- 2018/12/12 06:00 CRDT- 2018/08/06 06:00 PHST- 2018/08/06 06:00 [entrez] PHST- 2018/08/07 06:00 [pubmed] PHST- 2018/12/12 06:00 [medline] AID - 10.3760/cma.j.issn.0376-2491.2018.28.010 [doi] PST - ppublish SO - Zhonghua Yi Xue Za Zhi. 2018 Jul 24;98(28):2258-2263. doi: 10.3760/cma.j.issn.0376-2491.2018.28.010.